Oncotarget

Research Papers:

Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer – a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation

Wei-Ling Chang _, Lih-Ching Hsu, Wohn-Jenn Leu, Ching-Shih Chen, Jih-Hwa Guh

PDF |  HTML  |  Supplementary Files  |  Author Information  |  Order a Reprint

Oncotarget. 2015; 6:39806-39820. https://doi.org/10.18632/oncotarget.5655

Metrics: PDF 472 views  |   HTML 325 views  |   ?  


Abstract

Wei-Ling Chang1,2, Lih-Ching Hsu2, Wohn-Jenn Leu2, Ching-Shih Chen1, Jih-Hwa Guh2

1The Division of Medicinal Chemistry, College of Pharmacy, Ohio State University, Columbus, OH 43210, USA

2School of Pharmacy, National Taiwan University, Taipei 100, Taiwan

Correspondence to:

Ching-Shih Chen, e-mail: chen.844@osu.edu

Jih-Hwa Guh, e-mail: jhguh@ntu.edu.tw

Keywords: Nitroxoline, AMPK/mTOR signaling, Chk2, G1 arrest, Cyclin D1-Rb-Cdc25A axis

Received: July 10, 2015     Accepted: September 21, 2015     Published: October 03, 2015

ABSTRACT

Nitroxoline is an antibiotic by chelating Zn2+ and Fe2+ from biofilm matrix. In this study, nitroxoline induced G1 arrest of cell cycle and subsequent apoptosis in prostate cancer cells through ion chelating-independent pathway. It decreased protein levels of cyclin D1, Cdc25A and phosphorylated Rb, but activated AMP-activated protein kinase (AMPK), a cellular energy sensor and signal transducer, leading to inhibition of downstream mTOR-p70S6K signaling. Knockdown of AMPKα significantly rescued nitroxoline-induced inhibition of cyclin D1-Rb-Cdc25A axis indicating AMPK-dependent mechanism. However, cytoprotective autophagy was simultaneously evoked by nitroxoline. Comet assay and Western blot analysis demonstrated DNA damaging effect and activation of Chk2 other than Chk1 to nitroxoline action. Instead of serving as a DNA repair transducer, nitroxoline-mediated Chk2 activation was identified to function as a pro-apoptotic inducer. In conclusion, the data suggest that nitroxoline induces anticancer activity through AMPK-dependent inhibition of mTOR-p70S6K signaling pathway and cyclin D1-Rb-Cdc25A axis, leading to G1 arrest of cell cycle and apoptosis. AMPK-dependent activation of Chk2, at least partly, contributes to apoptosis. The data suggest the potential role of nitroxoline for therapeutic development against prostate cancers.

Author Information

Wei-Ling Chang
Primary Contact  _

Lih-Ching Hsu

Wohn-Jenn Leu

Ching-Shih Chen

Jih-Hwa Guh


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 5655